| 1994 |
eIF5 forms a specific complex with eIF2 in a 1:1 stoichiometry (apparent Mr ~160 kDa), and this interaction is required for eIF5 to catalyze hydrolysis of GTP bound to the 40S initiation complex and promote 80S initiation complex formation. |
Glycerol gradient sedimentation, in vitro GTPase assay with purified recombinant eIF5 |
Biochemistry |
High |
8161539
|
| 1998 |
eIF5 stably associates with the yeast eIF3 core complex (composed of Tif32p/eIF3a, Nip1p/eIF3c, Prt1p/eIF3b, Tif34p/eIF3i, Tif35p/eIF3g); Nip1p/eIF3c directly binds eIF5 in two-hybrid and in vitro binding assays. |
Ni2+ affinity purification of His-Prt1p complex, mass spectrometry, yeast two-hybrid, in vitro protein binding |
Molecular and cellular biology |
High |
9671501
|
| 2000 |
eIF5 bridges interaction between eIF3 (via NIP1/eIF3c N-terminus) and eIF2 (via eIF2β N-terminal half) through a conserved bipartite motif in the eIF5 C-terminal domain (CTD), forming a multifactor complex (MFC) that also contains eIF1 and initiator tRNA(Met) in vivo. The tif5-7A mutation in the bipartite motif disrupts MFC assembly and causes temperature-sensitive growth and reduction in translation initiation. |
In vitro protein binding, co-immunoprecipitation from yeast cell extracts, genetic analysis (tif5-7A mutant) |
Genes & development |
High |
11018020
|
| 2000 |
The C-terminus of eIF5 (glutamic acid-rich bipartite motif) is required for interaction with the β subunit of eIF2; alanine substitution of conserved glutamic acid residues (E346A/E347A and E384A/E385A) abolishes eIF5–eIF2β binding, GTP hydrolysis, 80S initiation complex formation, and in vivo cell viability. |
Deletion and alanine substitution mutagenesis, in vitro binding assays, GTPase assay, yeast complementation |
Molecular and cellular biology |
High |
10805737
|
| 2001 |
eIF5 acts as a classical GTPase-activating protein (GAP) for eIF2: its interaction with eIF2 is enhanced by AlF4- (mimicking the transition state), and it contains an 'arginine finger' (Arg15) flanked by hydrophobic residues; mutation R15M abolishes both GTP hydrolysis stimulation and in vitro mRNA translation. Arg48 also contributes to the GTPase active site. |
AlF4- binding assay, site-directed mutagenesis (R15M, R48M), in vitro GTPase assay, in vitro translation assay |
Current biology |
High |
11166181
|
| 2001 |
The eIF5-CTD simultaneously binds eIF4G (cap-binding complex subunit) and eIF3/NIP1, suggesting it bridges the cap-binding complex to the PIC. In vivo, the tif5-7A mutation (disrupting MFC) eliminates eIF5 from the pre-initiation complex and causes accumulation of 48S complexes, indicating GTP hydrolysis/conversion of 48S to 80S is the rate-limiting step. |
In vitro protein binding, GST pulldown, polysome/ribosome sedimentation analysis, in vivo crosslinking |
The EMBO journal |
High |
11331597
|
| 2003 |
eIF5 makes critical contacts with the 40S ribosomal subunit in vivo, performing redundant functions with the TIF32-CTD of eIF3a for 40S binding. The TIF32-CTD binds helices 16–18 of 18S rRNA in vitro, and NIP1/eIF5 interact with 40S protein RPS0A. |
In vivo co-immunoprecipitation from yeast, in vitro RNA binding assay, deletion analysis |
Genes & development |
Medium |
12651896
|
| 2003 |
The eIF4G HEAT domain interacts with eIF5 (and eIF1); eIF1 binds simultaneously to eIF4G and eIF3c in vitro; mutations disrupting eIF4G–eIF5 interaction lead to elevated non-AUG initiation in vivo, indicating the eIF4G HEAT domain–eIF5/eIF1 interaction is important for scanning preinitiation complex integrity and AUG stringency. |
In vitro protein binding, two-hybrid, in vivo genetic suppression, reporter assay for non-AUG initiation |
Molecular and cellular biology |
Medium |
12861028
|
| 2004 |
The N-terminal domain (NTD) of NIP1/eIF3c directly binds eIF1 and eIF5 to form the MFC; specific NIP1-NTD mutations reduce eIF1 or eIF5 binding, alter UUG start codon utilization (Sui- phenotype), and impair TC recruitment to 40S ribosomes. eIF1 overexpression suppresses the Sui- phenotype of both NIP1 and eIF5-G31R mutants, indicating that NIP1-NTD coordinates eIF1–eIF5 interaction to inhibit GTP hydrolysis at non-AUG codons. |
Site-directed mutagenesis of NIP1-NTD, yeast genetics (Sui- phenotype assay), in vitro binding, eIF1/eIF5 overexpression suppression |
Molecular and cellular biology |
High |
15485912
|
| 2006 |
Crystal structure of the human eIF5-CTD at high resolution shows it is exclusively α-helical and homologous to the eIF2Bε-CTD (W2/HEAT domain). The binding sites for eIF2β, eIF3c, and eIF1 were mapped onto the structure: eIF2β and eIF3c bind non-overlapping patches of negative and positive electrostatic potential, respectively. |
X-ray crystallography (crystal structure), electrostatic surface analysis |
Journal of molecular biology |
High |
16781736
|
| 2006 |
Crystal structure of the S. cerevisiae eIF5-CTD at 1.5 Å confirms it contains an atypical HEAT motif; surface analysis identifies conserved potential interaction regions for partner eIFs. |
X-ray crystallography |
Journal of molecular biology |
High |
16616930
|
| 2007 |
eIF1 has two distinct eIF5-binding faces: its N-terminal tail and a basic/hydrophobic surface (KH region). Mutation of the KH region is lethal and causes dominant relaxation of start codon selection. The eIF1 N-terminal tail plays a stimulatory role in cooperative MFC assembly. |
NMR solution structure of yeast eIF1 used for interface mapping, yeast two-hybrid, in vitro binding, genetic analysis |
The Journal of biological chemistry |
High |
17974565
|
| 2010 |
eIF5 has a GDP dissociation inhibitor (GDI) activity distinct from its GAP function: it stabilizes GDP binding to eIF2 between rounds of initiation. Conserved residues in eIF5 are required specifically for GDI (not GAP) activity. eIF5 is also a critical component of the eIF2(αP) regulatory complex that inhibits eIF2B GEF activity. |
Fluorescence nucleotide binding assays, mutagenesis of eIF5 GDI-specific residues, genetic assays (GCN4 translational control), in vitro GEF inhibition assay |
Nature |
High |
20485439
|
| 2013 |
eIF2B acts as a GDI displacement factor (GDF) that recruits eIF2 from the eIF2•GDP/eIF5 GDI complex prior to GEF action; GDF activity depends on eIF2Bε and eIF2Bγ subunits and is insensitive to eIF2α phosphorylation (unlike GEF). eIF2B GDF and GEF activities are independent. |
Protein-protein interaction assays, fluorescent nucleotide exchange kinetic assays, mutagenesis of eIF2B subunits |
Genes & development |
High |
24352424
|
| 2013 |
Upon AUG codon recognition, the C-terminal tail (CTT) of eIF1A moves closer to the eIF5 NTD; this movement is coupled to eIF1 dissociation from the PIC. eIF1 dissociation plus eIF1A-CTT movement toward eIF5 is required to trigger Pi release from eIF2•GDP•Pi. The eIF5-CTD antagonizes eIF1 binding to the PIC. |
FRET-based distance measurements in reconstituted yeast PICs, mutagenesis, phosphate release assays |
The Journal of biological chemistry |
High |
23293029
|
| 2014 |
eIF5-G31R (Sui- mutation) alters Pi release: it accelerates Pi release at UUG codons and decreases it at AUG codons, stabilizing the closed PIC conformation at UUG. Suppressor G62S mitigates both defects; suppressor M18V primarily impairs GTP hydrolysis with little effect on PIC conformation, indicating eIF5 controls both Pi release and open-to-closed PIC conformational transitions for accurate AUG selection. |
In vitro GTP hydrolysis assays, Pi release assays, FRET-based PIC conformation assays, mutagenesis |
Nucleic acids research |
High |
25114053
|
| 2014 |
eIF5 and eIF5B together stimulate 48S initiation complex formation during ribosomal scanning; eIF5-induced hydrolysis of eIF2-bound GTP is essential for this stimulation, increasing the probability that scanning complexes arrest at non-optimal start codons. eIF5B then stabilizes the initiator tRNA in the P site after eIF2•GDP dissociation. |
In vitro 48S IC assembly assays, GTPase assays, mutagenesis of eIF1A and eIF5B |
Nucleic acids research |
High |
25260592
|
| 2002 |
Casein kinase II (CK II) phosphorylates mammalian eIF5 in vitro and in vivo at Ser-387 and Ser-388 near the C-terminus (within an acidic cluster), accounting for ~90% of total phosphorylation; a minor site is Ser-174. Alanine substitution at S387/S388 abolishes both in vitro and in vivo phosphorylation. |
Kinase isolation and biochemical characterization, mass spectrometry of phosphorylation sites, alanine substitution mutagenesis, in vivo 32P labeling |
Nucleic acids research |
High |
11861906
|
| 2003 |
In S. cerevisiae, eIF5 is phosphorylated in vivo on multiple serine residues by casein kinase II; phosphopeptide mapping reveals four major sites identical to in vitro CK II sites. However, Ser-to-Ala mutations at all five CK II consensus sites in eIF5 had no obvious effect on cell growth under normal conditions. |
In vivo 32P labeling and phosphopeptide mapping, conditional CK II mutant yeast strain, site-directed mutagenesis |
Yeast |
Medium |
12518314
|
| 2017 |
The eIF3c N-terminal domain (NTD) is divided into 3c0, 3c1, and 3c2 sub-regions; 3c0 binds eIF5 strongly but only weakly to eIF1's ribosome-binding surface, while 3c1/3c2 form a stoichiometric complex with eIF1. The 3c0:eIF5 interaction stabilizes the scanning PIC by preventing the inhibitory 3c0:eIF1 interaction; upon start codon recognition, interactions involving eIF5 and ultimately 3c0:eIF1 facilitate eIF1 release. |
NMR, in vitro binding assays, mutagenesis of NIP1-NTD subregions |
Cell reports |
High |
28297669
|
| 2018 |
Cryo-EM structure (3.0 Å) of a yeast 48S PIC shows the eIF5-NTD bound to the 40S subunit at the location vacated by eIF1; eIF5-NTD interacts with Met-tRNAi to allow a more accommodated (PIN) orientation. Substitutions of eIF5 residues at the eIF5-NTD/tRNAi interface influence initiation at near-cognate UUG codons in vivo and closed/open PIC conformation in vitro. |
Cryo-EM reconstruction, in vivo UUG initiation assays, in vitro PIC conformation assays, mutagenesis |
eLife |
High |
30475211
|
| 2018 |
Human eIF5 interacts with eIF5B via a C-terminal eIF5B-binding motif, competing with eIF1A for eIF5B binding with ~100-fold higher affinity than eIF1A; this interaction may coordinate start codon selection (eIF5 as GAP of eIF2) with ribosomal subunit joining (eIF5B), with eIF1A displacing eIF5 from eIF5B to allow the eIF5:eIF2-GDP complex to leave the ribosome. |
Binding affinity measurements (ITC/fluorescence), competition assays, identification of eIF5B-binding motif in eIF5 |
Biochemistry |
Medium |
30211544
|
| 2016 |
eIF2β acts in concert with eIF5 to prevent premature GDP release from eIF2γ: a growth suppressor mutation in eIF2β specifically prevents eIF5 GDI from stabilizing GDP binding to eIF2 (increases GDP off-rate from eIF2•GDP/eIF5 complexes) without affecting intrinsic eIF2 affinities for GDP or initiator tRNA, impairing GCN4 translational control. |
Fluorescent nucleotide binding kinetics assays, genetic analysis (GCN4 derepression), mutagenesis of eIF2β |
Nucleic acids research |
High |
27458202
|
| 2021 |
Human eIF5 contains two intrinsically disordered regions (IDRs): the DWEAR motif and the C-terminal tail (CTT), which dynamically contact the folded CTD and compete with each other. CTD•CTT interaction favors eIF2β binding to eIF5-CTD, whereas CTD•DWEAR interaction favors eIF1A binding. CK2 phosphorylation significantly increases eIF5 affinity for eIF2; eIF2β has at least two (likely three) eIF5-binding sites. |
NMR spectroscopy, binding assays, phosphomimetic mutagenesis |
Biophysical chemistry |
Medium |
34923394
|
| 2022 |
CK2 phosphorylation of eIF5 increases its affinity for eIF1A; a new contact interface was identified between eIF5-CTD and the OB domain of eIF1A. Dynamic intramolecular interactions within both eIF5 and eIF1A modulate this interaction. |
Binding assays, phosphomimetic mutagenesis of eIF5, NMR/structural analysis |
Current research in structural biology |
Medium |
36164648
|
| 2024 |
eIF5 (via its GAP activity) preferentially stimulates poly-GA RAN translation from a CUG near-cognate start codon in C9orf72 FTLD/ALS; inactive eIF5 mutants do not stimulate. Mutation of the CUG to CCG or AUG abolishes the stimulatory effect. In a Drosophila C9orf72 model, knockdown of eIF5 reduces poly-GA expression in vivo. |
Transfection of WT and inactive eIF5 mutants, RAN translation reporters, codon mutation analysis, Drosophila RNAi knockdown |
The Journal of biological chemistry |
Medium |
38301895
|
| 2024 |
Single-molecule fluorescence analysis of human translation initiation showed that eIF5 only transiently binds initiation complexes late in initiation immediately prior to eIF5B association; eIF5 association requires a translation start site and is inhibited by alternative start sites. eIF1 and eIF5 have opposing roles during initiation (knockdown/overexpression experiments in human cells confirmed this). |
Single-molecule fluorescence (smFRET/TIRF) on reconstituted human PICs, knockdown and overexpression in human cells |
bioRxivpreprint |
Medium |
39026837
|
| 2025 |
Crystal structure of yeast eIF5-CTD in complex with eIF2β K-box 3 reveals an extended binding site on eIF2β beyond the K-box. eIF2β has three distinct binding sites (one per K-box), and human eIF5, eIF2Bε, and 5MP1 can all bind to all three sites while reducing each other's affinities. CK2 phosphomimetic mutations in eIF5 increase affinities for all these partners, and eIF2B speeds dissociation of eIF5 from eIF2-GDP to promote nucleotide exchange. |
X-ray crystallography, NMR, binding assays with phosphomimetic mutants |
RNA |
High |
40670154
|
| 2012 |
Sequential binding of eIF5-CTD to the eIF4G RS1 domain and eIF2β K-boxes stabilizes the 48S PIC and promotes its shift to initiation mode: eIF4G-RS1/eIF5-CTD interaction directly links eIF4G to the PIC to enhance mRNA binding; eIF2β-K-boxes increase mRNA binding in a manner reversed by eIF5-CTD; mutations in these interactions restore AUG selection accuracy impaired by an eIF2β mutation. |
In vitro 48S complex assembly, mRNA binding assays, in vivo start codon selection assays, mutagenesis |
Molecular and cellular biology |
Medium |
22851688
|